Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of selective PDE IV inhibitors to treat dry eye disorders

Use of selective PDE IV inhibitors to treat dry eye disorders

US Patent 6872382 · Granted Mar 29, 2005

Estimated economic value: $67,827,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method for treating pruritus2025
Fixation members, assemblies, and related systems and methods2023
RNAi-mediated inhibition of phosphodiesterase type 4 for treatment of CAMP-relat2017
RNAi-mediated inhibition of phosphodiesterase type 4 for treatment of CAMP-relat2017
RNAi-mediated inhibition of histamine receptor H1-related conditions2017
RNAi-mediated inhibition of histamine receptor H1-related conditions2017
High concentration olopatadine ophthalmic composition2017
RNAi-mediated inhibition of phosphodiesterase type 4 for treatment of cAMP-relat2016
RNAi-mediated inhibition of phosphodiesterase type 4 for treatment of cAMP-relat2016
RNAi-mediated inhibition of tumor necrosis factor α-related conditions2016
RNAi-mediated inhibition of tumor necrosis factor α-related conditions2016
RNAi-mediated inhibition of spleen tyrosine kinase-related inflammatory conditio2016